Alternative protein is no longer limited to ESG investment theses. Breakthroughs in the space have brought it to the attention of a broader investor base, and the pandemic has underlined its importance as part of any forward-looking investment thesis. Andrew Ive, General Partner at Big Idea Ventures, is joined by Dr. Dalal Alghawas, Program Director at Big Idea Ventures Singapore and Nieves Martínez Marshall, Founder & CEO of Novel Farms, to discuss investment trends they see in the space, remaining gaps in the market and innovations we can anticipate in the future.
Recent Posts
- Mimicking whitefish with plants: Meet the Icelandic start-up developing Arctic seafood alternatives
- Bright Biotech Closes Oversubscribed Round for “Game-Changing” Plant Chloroplast Technology
- Melibio’s Bee-Free Honey to Launch in Europe Next Year
- Hooked Foods Grows by 25% Month Over Month, is Inundated With Positive Reviews
- Breaking: Upside Foods Earns FDA GRAS Status for Its Cultivated Meat in ‘Watershed Moment’